You are here

  • Home
  • Archive
  • Volume 12, Issue 1
  • Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
Peritumoral administration of immunomodulatory antibodies as a triple combination suppresses skin tumor growth without systemic toxicity

 

Online download statistics by month:

Online download statistics by month: January 2024 to July 2025

AbstractFullPdf
Jan 2024787820
Feb 2024758774245
Mar 2024234236124
Apr 202410710754
May 2024818335
Jun 2024899243
Jul 2024969637
Aug 2024696727
Sep 20246566331
Oct 2024646841
Nov 2024565729
Dec 2024616326
Jan 2025707029
Feb 2025979723
Mar 2025414121
Apr 2025727228
May 2025545625
Jun 2025202014
Jul 2025330
Total211521461152